logo

Freeline Therapeutics Holdings Plc (FRLN)



Trade FRLN now with
  Date
  Headline
7/10/2022 11:35:22 AM Freeline Presents Positive Initial Clinical Data From B-LIEVE Trial For FLT180a In Hemophilia B At ISTH Congress
3/9/2022 4:54:48 PM Wedbush Reiterates Freeline Therapeutics Holdings plc (FRLN) At Outperform With $10 Price Target
12/14/2021 4:31:20 PM Wedbush Reiterates Freeline Therapeutics Holdings plc (FRLN) At Outperform With $10 Down From $12 Price Target
9/9/2021 7:36:37 AM Freeline Announces Orphan Drug Designations For FLT201 For Gaucher Disease
6/16/2021 7:10:56 AM Freeline Doses Second Patient In Phase 1/2 MARVEL-1 Clinical Trial For Fabry Disease
3/11/2021 7:17:04 AM Freeline Appoints Colin Love To Board